Cargando…

Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease

BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (DA) neurons, a dopamine-depleted striatum, and microglial activation. Lipid accumulation exhibits a close relationship with these pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Jiewen, Peng, Guoyou, Tang, Yuting, Li, Shiyin, Liu, Zengfu, Zheng, Jiayun, Wang, Yunxin, Liu, Hanqun, Wei, Lijian, Su, Yilin, Lin, Yuwan, Dai, Wei, Zhang, Zhiling, Chen, Xiang, Ding, Liuyan, Guo, Wenyuan, Zhu, Xiaoqin, Xu, Pingyi, Mo, Mingshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895836/
https://www.ncbi.nlm.nih.gov/pubmed/36742201
http://dx.doi.org/10.3389/fnagi.2022.1077738
_version_ 1784881930938875904
author Qiu, Jiewen
Peng, Guoyou
Tang, Yuting
Li, Shiyin
Liu, Zengfu
Zheng, Jiayun
Wang, Yunxin
Liu, Hanqun
Wei, Lijian
Su, Yilin
Lin, Yuwan
Dai, Wei
Zhang, Zhiling
Chen, Xiang
Ding, Liuyan
Guo, Wenyuan
Zhu, Xiaoqin
Xu, Pingyi
Mo, Mingshu
author_facet Qiu, Jiewen
Peng, Guoyou
Tang, Yuting
Li, Shiyin
Liu, Zengfu
Zheng, Jiayun
Wang, Yunxin
Liu, Hanqun
Wei, Lijian
Su, Yilin
Lin, Yuwan
Dai, Wei
Zhang, Zhiling
Chen, Xiang
Ding, Liuyan
Guo, Wenyuan
Zhu, Xiaoqin
Xu, Pingyi
Mo, Mingshu
author_sort Qiu, Jiewen
collection PubMed
description BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (DA) neurons, a dopamine-depleted striatum, and microglial activation. Lipid accumulation exhibits a close relationship with these pathologies in PD. METHODS: Here, 6-hydroxydopamine (6-OHDA) was used to construct a rat model of PD, and the lipid profile in cerebrospinal fluid (CSF) obtained from model rats was analyzed using lipidomic approaches. RESULTS: Establishment of this PD model was confirmed by apomorphine-induced rotation behaviors, loss of DA neurons, depletion of dopamine in the striatum, and microglial activation after 6-OHDA-induced lesion generation. Unsupervised and supervised methods were employed for lipid analysis. A total of 172 lipid species were identified in CSF and subsequently classified into 18 lipid families. Lipid families, including eicosanoids, triglyceride (TG), cholesterol ester (CE), and free fatty acid (FFA), and 11 lipid species exhibited significantly altered profiles 2 weeks after 6-OHDA administration, and significant changes in eicosanoids, TG, CE, CAR, and three lipid species were noted 5 weeks after 6-OHDA administration. During the period of 6-OHDA-induced lesion formation, the lipid families and species showed concentration fluctuations related to the recovery of behavior and nigrostriatal abnormalities. Correlation analysis showed that the levels of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) exhibited positive relationships with apomorphine-induced rotation behaviors and negative relationships with tyrosine hydroxylase (TH) expression in the midbrain. CONCLUSION: These results revealed that non-progressive nigrostriatal degeneration induced by 6-OHDA promotes the expression of an impairment-related lipidomic signature in CSF, and the level of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) in CSF may reveal pathological changes in the midbrain after 6-OHDA insult.
format Online
Article
Text
id pubmed-9895836
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98958362023-02-04 Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease Qiu, Jiewen Peng, Guoyou Tang, Yuting Li, Shiyin Liu, Zengfu Zheng, Jiayun Wang, Yunxin Liu, Hanqun Wei, Lijian Su, Yilin Lin, Yuwan Dai, Wei Zhang, Zhiling Chen, Xiang Ding, Liuyan Guo, Wenyuan Zhu, Xiaoqin Xu, Pingyi Mo, Mingshu Front Aging Neurosci Neuroscience BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (DA) neurons, a dopamine-depleted striatum, and microglial activation. Lipid accumulation exhibits a close relationship with these pathologies in PD. METHODS: Here, 6-hydroxydopamine (6-OHDA) was used to construct a rat model of PD, and the lipid profile in cerebrospinal fluid (CSF) obtained from model rats was analyzed using lipidomic approaches. RESULTS: Establishment of this PD model was confirmed by apomorphine-induced rotation behaviors, loss of DA neurons, depletion of dopamine in the striatum, and microglial activation after 6-OHDA-induced lesion generation. Unsupervised and supervised methods were employed for lipid analysis. A total of 172 lipid species were identified in CSF and subsequently classified into 18 lipid families. Lipid families, including eicosanoids, triglyceride (TG), cholesterol ester (CE), and free fatty acid (FFA), and 11 lipid species exhibited significantly altered profiles 2 weeks after 6-OHDA administration, and significant changes in eicosanoids, TG, CE, CAR, and three lipid species were noted 5 weeks after 6-OHDA administration. During the period of 6-OHDA-induced lesion formation, the lipid families and species showed concentration fluctuations related to the recovery of behavior and nigrostriatal abnormalities. Correlation analysis showed that the levels of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) exhibited positive relationships with apomorphine-induced rotation behaviors and negative relationships with tyrosine hydroxylase (TH) expression in the midbrain. CONCLUSION: These results revealed that non-progressive nigrostriatal degeneration induced by 6-OHDA promotes the expression of an impairment-related lipidomic signature in CSF, and the level of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) in CSF may reveal pathological changes in the midbrain after 6-OHDA insult. Frontiers Media S.A. 2023-01-20 /pmc/articles/PMC9895836/ /pubmed/36742201 http://dx.doi.org/10.3389/fnagi.2022.1077738 Text en Copyright © 2023 Qiu, Peng, Tang, Li, Liu, Zheng, Wang, Liu, Wei, Su, Lin, Dai, Zhang, Chen, Ding, Guo, Zhu, Xu and Mo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Qiu, Jiewen
Peng, Guoyou
Tang, Yuting
Li, Shiyin
Liu, Zengfu
Zheng, Jiayun
Wang, Yunxin
Liu, Hanqun
Wei, Lijian
Su, Yilin
Lin, Yuwan
Dai, Wei
Zhang, Zhiling
Chen, Xiang
Ding, Liuyan
Guo, Wenyuan
Zhu, Xiaoqin
Xu, Pingyi
Mo, Mingshu
Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
title Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
title_full Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
title_fullStr Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
title_full_unstemmed Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
title_short Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
title_sort lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895836/
https://www.ncbi.nlm.nih.gov/pubmed/36742201
http://dx.doi.org/10.3389/fnagi.2022.1077738
work_keys_str_mv AT qiujiewen lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT pengguoyou lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT tangyuting lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT lishiyin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT liuzengfu lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT zhengjiayun lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT wangyunxin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT liuhanqun lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT weilijian lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT suyilin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT linyuwan lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT daiwei lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT zhangzhiling lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT chenxiang lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT dingliuyan lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT guowenyuan lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT zhuxiaoqin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT xupingyi lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease
AT momingshu lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease